Results 131 to 140 of about 96,663 (275)

Studies of Coagulation and Fibrinolysis by New Technic of Continuous Recording [PDF]

, 1955
Kurt N. von Kaulla, Murray Weiner
openalex   +1 more source

Effect of P2Y12 Inhibitors on Major Adverse Cardiovascular Events After Coronary Artery Bypass Graft Surgery: A Population‐Based Cohort Study

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Volume 45, Issue 9, Page 557-565, September 2025.
ABSTRACT Background Patients who undergo coronary artery bypass graft (CABG) surgery remain at high risk for major adverse cardiovascular events (MACE) despite contemporary preventive pharmacotherapy. Although commonly used in practice, it is uncertain whether P2Y12 inhibitors reduce MACE in patients post‐CABG surgery.
Arden R. Barry, Hamed Helisaz, Abdollah Safari, Peter S. Loewen   +3 more
wiley   +1 more source

FIBRINOLYSIS [PDF]

, 1959

openalex   +1 more source

The factor VII activating protease G511E (Marburg) variant and cardiovascular risk [PDF]

, 2004
A previous study had shown a strong relationship between a variant in factor VII activating protease (FSAP G511E) and advanced carotid atheroma. In-vitro, the variant has reduced fibrinolytic but normal pro-coagulant activity, which may constitute a ...
Cooper, J.A., Humphries, S.E., Ireland, H., Miller, G.J., Webb, K.E.   +4 more
core  

The Contribution of Genetic Risk and Lifestyle Factors in the Progression of Diabetes to Diabetic Kidney Disease: A Prospective Cohort Study

Journal of Diabetes, Volume 17, Issue 9, September 2025.
The Contribution of Genetic Risk and Lifestyle Factors in the Progression of Diabetes to Diabetes Nephropathy. ABSTRACT Aims Diabetes is a global public health crisis, especially when it is accompanied by microvascular complications such as diabetic kidney disease (DKD).
Yujiao Wang, Chunyang Li, Nongbu Cili, Jing Chen, Huazhen Yang, Ping Fu, Xiaoxi Zeng   +6 more
wiley   +1 more source

Pharmacological enhancement of fibrinolysis. [PDF]

, 1969
G. R. Fearnley, Ranjan Chakrabarti
openalex   +1 more source

Why, how and in whom should we measure levels of lipoprotein(a): A review of the latest evidence and clinical implications

Diabetes, Obesity and Metabolism, Volume 27, Issue S8, Page 34-46, September 2025.
Abstract Lipoprotein(a) [Lp(a)] is a genetically determined, causal risk factor for atherosclerotic cardiovascular disease (ASCVD) and calcific aortic valve disease (CAVD). Despite robust evidence from epidemiological and genetic studies, Lp(a) remains underrecognised in clinical practice due to challenges in measurement, lack of guideline familiarity ...
Alexander C. Razavi, Harpreet S. Bhatia, Roger S. Blumenthal, Michael D. Shapiro, Anurag Mehta   +4 more
wiley   +1 more source

Abnormal Plasminogen-Plasmin System Activity (Fibrinolysis) in Patients with Hepatic Cirrhosis: Its Cause and Consequences* [PDF]

, 1964
Anthony P. Fletcher, Oliver Biederman, Don Moore, Norma Alkjærsig, Sol Sherry   +4 more
openalex   +1 more source

The role of the microbiome in endometrial carcinoma: Pathogenesis, biomarkers, and therapeutic prospects

Journal of Obstetrics and Gynaecology Research, Volume 51, Issue 9, September 2025.
Abstract Aim Recent studies show that human microbiomes play a significant role in the development of endometrial carcinoma, which is a common gynecological cancer affecting women of reproductive age. This review provides an extensive analysis of how the microbiome interacts with endometrial carcinoma while focusing on its impact on disease progression
Wafa Abdalla, Wisam Nabeel Ibrahim, Atiyeh M. Abdallah, Maha Abdulla Al‐Asmakh, Sawsan Sudqi Said   +4 more
wiley   +1 more source

Pathogenesis of Fibrinolysis in Defibrination Syndrome: Effect of Heparin Administration [PDF]

, 1964
C. Merskey, Alan J. Johnson, James H. Pert, Herbert Wohl   +3 more
openalex   +1 more source